首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   118篇
  免费   2篇
  国内免费   2篇
林业   3篇
基础科学   1篇
  1篇
综合类   17篇
畜牧兽医   97篇
植物保护   3篇
  2021年   1篇
  2020年   1篇
  2019年   2篇
  2017年   1篇
  2016年   1篇
  2015年   1篇
  2014年   6篇
  2013年   5篇
  2012年   3篇
  2011年   4篇
  2010年   2篇
  2009年   4篇
  2008年   6篇
  2007年   1篇
  2006年   2篇
  2005年   6篇
  2004年   3篇
  2003年   7篇
  2002年   4篇
  2001年   4篇
  2000年   4篇
  1999年   4篇
  1998年   7篇
  1997年   6篇
  1996年   4篇
  1995年   4篇
  1994年   2篇
  1993年   1篇
  1992年   1篇
  1991年   4篇
  1990年   1篇
  1989年   1篇
  1988年   2篇
  1987年   2篇
  1986年   6篇
  1985年   1篇
  1982年   2篇
  1981年   1篇
  1978年   1篇
  1972年   1篇
  1971年   3篇
排序方式: 共有122条查询结果,搜索用时 0 毫秒
91.
92.

Introduction  

Knowledge of vertical variation in hydraulic parameters would improve our understanding of individual trunk functioning and likely have important implications for modeling water movement to the leaves. Specifically, understanding how foliage area (A l), sapwood area (A s), and hydraulic specific conductivity (k s) vary with canopy position to affect leaf-specific conductivity (LSC) and whole-tree leaf-specific hydraulic conductance (K l) may explain some of the contrasting patterns of A l/A s reported in the literature.  相似文献   
93.
A delayed‐release formulation of liposome‐encapsulated oxymorphone was produced using a novel dehydration–rehydration technique. The purpose of this study was to (i) compare the analgesic properties of this preparation with those of repeated injections of standard oxymorphone in rats with post‐operative visceral pain and (ii) determine whether liposome‐encapsulated oxymorphone differed from standard oxymorphone in duration of the effect. Visceral pain was elicited in approximately 300 g Sprague–Dawley rats by intestinal resection performed under isoflurane anesthesia. Rats were monitored with pulse oximetry; mean anesthesia time (35 ± 10 minutes) did not differ between the groups. Rats were randomly divided into two groups: Group 1 received 1.2 mg kg?1 liposome‐encapsulated oxymorphone SC once at skin closure and 0.2 mL of saline SC every 4 hours; Group 2 received 0.2 mL liposome‐encapsulated sucrose SC once at skin closure and 0.3 mg kg?1 standard oxymorphone SC every 4 hours. In both groups, a behavioral ethogram for pain score (grooming, porphyrin staining, body position) was recorded every 4 hours for 48 hours after surgery. Observers were blinded to the treatment. Body weight, food consumption, and urine output were recorded daily for 7 days after anesthetic recovery. Data were analyzed using anova , with significance at p < 0.05. Based on the behavioral pain score, a single injection of liposome‐encapsulated oxymorphone was as effective for relief of post‐surgical visceral pain in rats as multiple (every 4 hours) injections of standard oxymorphone administered over a 48 hour period (p = 0.18). In rats, given one dose of liposome‐encapsulated oxymorphone, the mean body weight change from day 0 to day 7 was +9.4 g, whereas rats given multiple injections of standard oxymorphone had a mean body weight change of ?3.6 g over this time (p < 0.01). Mean daily food consumption was significantly less in rats given multiple injections of standard oxymorphone (p < 0.05). There was no difference between groups in urine production. In conclusion, a single dose of liposome‐encapsulated oxymorphone was effective in treating visceral pain in rats. Rats treated with liposome‐encapsulated oxymorphone had improved recovery, based on body weight changes and food consumption, compared with rats treated with multiple doses of standard oxymorphone. Liposome‐encapsulated oxymorphone offered advantages including provision of effective analgesia, prolonged dosing intervals, and minimal handling stress.  相似文献   
94.
95.
Our lab has developed a slow‐release liposomal formulation of oxymorphone (LEOx). The purpose of this study was to compare serum concentrations of oxymorphone after administration of LEOx and standard oxymorphone (STDOx) to healthy female rhesus macaques. At baseline, 1 mL of blood was drawn from the femoral vein with the animal in a restraint cage. Primates were divided into two groups: (i) LEOx 1.0 mg kg–1(n = 4); 2) STDOx 0.1 mg kg–1(n = 4). Unloaded liposomal vehicle (0.5 mL) was used as a control (n = 2). All treatments were given subcutaneously in a shaved area proximal to the right ileal wing. Femoral venous blood was drawn and serum concentrations of drug were measured at 0.5, 1, 2, 4, 8, 12, 24, 48, 72, 96, and 120 hours. Serum concentrations were measured with ELISA. Serum concentrations were compared between groups and within groups across time with anova . Drug was not detected at any time point in the control group. While sedation was not objectively measured, no animal appeared overly sedate after either treatment. All animals willingly accepted treats and did not appear nauseated or somnolent. Serum concentrations of drug were not significantly different between the two treatment groups from 0 to 2 hours. From 4 hours through 72 hours, however, serum concentrations were significantly higher (p < 0.05) in the animals that received LEOx. By 12 hours, serum concentrations of drug fell below the limit of detection (1.5 ng mL–1) in animals that received STOx. In animals that received LEOx, serum concentrations at 72 hours were comparable to those measured at 4 hours in animals that received STOx. These results suggest that subcutaneous administration of liposomal oxymorphone yields extended serum levels of drug. These results also suggest that liposomal oxymorphone may provide therapeutic (i.e. analgesic) serum concentrations of drug for 2–3 days after a single subcutaneous administration. Further studies are warranted to assess analgesic efficacy and pharmacokinetics of lipsomal oxymorphone in primates.  相似文献   
96.
Our lab has developed a slow‐release liposomal formulation of oxymorphone (LEOx). The purpose of this study was to compare sedative effects and serum concentrations of oxymorphone after administration of LEOx and standard oxymorphone (STDOx) to dogs. At baseline, 1 mL of blood was drawn from the cephalic vein and sedation score was recorded. Dogs were divided into four groups (n = 6): (i) LEOx 1.0 mg kg–1; (ii) LEOx 0.5 mg kg–1; (iii) STDOx 0.1 mg kg–1; (iv) STDOx 0.05 mg kg–1. Unloaded liposomal vehicle (0.5 mL) was used as a control (n = 2). All treatments were given subcutaneously between the scapulae. Sedation score and serum concentration of drug were recorded at 0.5, 1, 2, 4, 8, 12, 16, 24 hours and daily for 5 days. Serum concentrations were measured with ELISA. At all time points, drug was not detected and sedation score was 0 in the control group. Sedation score for group 1 was significantly higher (p < 0.05) at 1 hour than for groups 2,3, and 4. There was no difference in sedation score between treatment groups at any other time. Serum concentrations of drug were significantly higher (p < 0.05) for group 1 at all time points measured after baseline. In groups 2, 3, and 4, serum concentrations of drug fell below the limit of detection (1.5 ng mL–1) by 24 hours. Serum concentrations after 0.1 mg kg–1of STDOx were 11.1 ± 3.6 ng mL–1at 4 hours, which is the recommended time for redosing and presumably reflects the lower end of a therapeutic serum concentration. Serum concentrations were comparable after 1.0 mg kg–1 of LEOx (10.5 ± 2.4 ng mL–1) 48 hours after administration. These results suggest that liposomal oxymorphone may provide therapeutic serum concentrations of drug for 2 days after a single subcutaneous administration without undue sedation or other deleterious effects in healthy dogs. Further studies are warranted to assess analgesic efficacy and pharmacokinetics of lipsomal oxymorphone in dogs.  相似文献   
97.
The objective of this study was to determine the effect of genotype and week postpartum on serum concentrations of IGF-I, body condition score (BCS), BW, and ovarian function in beef cows. Cows from the following genotypes were utilized in two consecutive years: Angus (A x A; n = 9), Brahman (B x B; n = 10), Charolais (C x C; n = 12), Angus x Brahman (A x B; n = 22), Brahman x Charolais (B x C; n = 19) and Angus x Charolais (A x C; n = 24). Serum concentrations of IGF-I, BCS, and BW were determined between wk 2 and 9 postpartum. Rectal ultrasound was used to determine days postpartum to first medium (6 to 9 mm) and first large (> or = 10 mm) follicle. Averaged across genotype, BCS decreased (P < 0.05) from 5.0 +/- 0.1 on wk 3 to 4.8 +/- 0.1 on wk 6 postpartum, and BW decreased (P < 0.05) between wk 2 and 3 and again between wk 4 and 9 postpartum. Averaged over year and week postpartum, serum IGF-I concentrations were greatest (P < 0.05) in B x B cows (46 +/- 5 ng/mL) compared with all other genotypes; lowest in A x A (12 +/- 4 ng/mL), C x C (13 +/- 4 ng/mL), and A x C cows (18 +/- 3 ng/mL); and intermediate (P < 0.05) in A x B (28 +/- 3 ng/mL) and B x C (26 +/- 3 ng/mL) cows compared with all other genotypes. Serum IGF-I concentrations did not change (P > 0.10) with week postpartum in C x C, A x A, and A x C cows, but increased (P < 0.05) between wk 2 and 7 postpartum in B x C, A x B, and B x B cows. Average interval to first medium (16 +/- 2 d) and first large (35 +/- 2 d) follicle did not differ (P > 0.10) among genotypes. Serum IGF-I concentrations correlated with BCS (r = 0.53 to 0.72, P < 0.001) but not with days to first large follicle (r = -0.19 to -0.22, P > 0.10). Averaged across genotypes, cows that lost BCS postpartum had lower (P < 0.01) serum IGF-I concentrations. Cows that calved with adequate BCS (i.e., > or = 5) had greater (P < 0.01) serum IGF-I concentrations postpartum than cows that calved with inadequate BCS (i.e., < 5) but days to first large and medium follicle did not differ (P > 0.10). In conclusion, concentrations of IGF-I in serum differed among genotypes and were associated with BCS but not days to first large or medium follicle in postpartum beef cows.  相似文献   
98.
Over the last several years there have been great improvements in the energy resolution and detection efficiency of angle-resolved photoemission spectroscopy. These improvements have made it possible to discover a number of fascinating features in the electronic structure of the high transition temperature (T(c)) superconductors: apparently bandlike Fermi surfaces, flat-band saddle points, and nested Fermi surface sections. Recent work suggests that these features, previously thought explainable only by one-electron band theory, may be better understood with a many-body approach. Furthermore, other properties of the high-T(c) superconductors, which are difficult to understand with band theory, are well described using a many-body picture. Angle-resolved photoemission spectroscopy has also been used to investigate the nature of the superconducting pairing state, revealing an anisotropic gap consistent with a d-wave order parameter and fueling the current debate over s-wave versus d-wave superconductivity.  相似文献   
99.
The availability of safe, commercially prepared stock feed for production animals is an important step in ensuring animal health and welfare and the safety of food animal products for human consumption. Animal feed quality assurance programs include microbiological monitoring of raw materials, mill equipment and finished feed. Over a period of 16 years, 23,963 samples for Salmonella culture and serotyping were collected from 22 stock feed mills. A multivariable generalized linear mixed model (GLMM) was used to identify mill and sample type factors that increase the odds of detecting Salmonella. The odds of detecting a Salmonella positive sample was greatest in samples from raw materials and in mills that processed restricted animal material (RAM). The percentage of positive samples ranged from 7.2% in 2003 to 2.8% in 2017. Of the 1,069 positive samples, 976 were serotyped with 61 different Salmonella serotypes isolated. The serotype most frequently isolated from raw materials was S. Agona, (n = 108) whilst S. Anatum was the serotype most frequently isolated from equipment and finished feed (n = 156). The diversity of Salmonella serotypes differed between mills and different stages of the production line. Microbiological monitoring in the commercial preparation of animal feed in Australian stock feed mills guides the implementation of quality control measures and risk mitigation strategies thereby reducing the prevalence and diversity of potentially zoonotic bacteria such as Salmonella, enhancing food safety for both animal and consumer.  相似文献   
100.
Long‐term experiments were conducted in two winter barley fields in central Spain to determine the spatial stability of Avena sterilis ssp. ludoviciana populations under annual applications of low rates of imazamethabenz herbicide. Weed density was sampled every year (over 5 years in the first field and over 3 years in the second) on the same grid locations prior to herbicide application. Although weed patches were stable in their location, weed density decreased in most of the years. In the first field, the populations decreased exponentially over the 5‐year period. The rates of population decline were dependent on the initial density of the population, being higher for the central core of the patches and lower for the low‐density areas. Under the conditions present in this experiment, it was possible to reduce heavy weed patches (up to 1200 seedlings m?2) down to relatively safe levels (18 seedlings m?2) in a period of 3 years using a density‐specific control programme, applying low rates of herbicides when weed densities were below a given level (1000 seedlings m?2). However, under adverse environmental conditions, half rates of the herbicide failed to control the weed populations adequately. The stability of the location of patches of A. sterilis ssp. ludoviciana suggest that weed seedling distributions mapped in one year are good predictors of future seedling distributions. However, the actual densities established each year will depend on the control level achieved the previous year and the climatic conditions present during the establishment period.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号